Replies to post #64801 on Sunshine Biopharma Inc (SBFM)

[Larry1955]

Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company.

The clinical stage drug candidate is Veyonda® (previously known as NOX-66). Veyonda® is a first-in-class, dual-acting cytotoxic and immuno-oncology drug candidate designed to enhance the effectiveness and safety of both chemotherapy and radiotherapy.